These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 2566230

  • 1. Serum aminoterminal propeptide of type III procollagen. A non-invasive test for liver fibrogenesis in methotrexate-treated psoriatics.
    Zachariae H, Søgaard H, Heickendorff L.
    Acta Derm Venereol; 1989; 69(3):241-4. PubMed ID: 2566230
    [Abstract] [Full Text] [Related]

  • 2. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
    Maurice PD, Maddox AJ, Green CA, Tatnall F, Schofield JK, Stott DJ.
    Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
    [Abstract] [Full Text] [Related]

  • 3. Aminoterminal propeptide of type III procollagen in methotrexate-induced liver fibrosis and cirrhosis.
    Risteli J, Søgaard H, Oikarinen A, Risteli L, Karvonen J, Zachariae H.
    Br J Dermatol; 1988 Sep; 119(3):321-5. PubMed ID: 3179204
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patients.
    vanDooren-Greebe RJ, Kuijpers AL, Buijs WC, Kniest PH, Corstens FH, Nagengast FM, de Boo T, Willems JL, Duller P, van de Kerkhof PC.
    Br J Dermatol; 1996 Mar; 134(3):481-7. PubMed ID: 8731673
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
    Trocme C, Leroy V, Sturm N, Hilleret MN, Bottari S, Morel F, Zarski JP.
    J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects on fibrogenesis markers of rheumatoid arthritis therapy with methotrexate.
    Biasi D, Bambara LM, Carletto A, Casaril M, Capra F, Caramaschi P, Corrocher R.
    J Rheumatol; 1996 Mar; 23(3):453-4. PubMed ID: 8832981
    [Abstract] [Full Text] [Related]

  • 15. Serum concentrations of extracellular matrix components: novel markers of metabolic control and hepatic pathology in glycogen storage disease?
    Calçado A, Trivedi P, Portmann B, Mowat AP.
    J Pediatr Gastroenterol Nutr; 1991 Jul; 13(1):1-9. PubMed ID: 1919939
    [Abstract] [Full Text] [Related]

  • 16. Aminoterminal propeptide of type III procollagen: a marker of hepatic fibrosis after bile duct obstruction in the monkey.
    Ruf G, Mappes HJ, Koch H, Baumgartner U, Hagmann W, Farthmann EH.
    Hepatogastroenterology; 1996 Jul; 43(7):121-6. PubMed ID: 8682446
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Methotrexate hepatotoxicity and concentrations of methotrexate and folate in erythrocytes--relation to liver fibrosis and cirrhosis.
    Zachariae H, Schrøder H, Foged E, Søgaard H.
    Acta Derm Venereol; 1987 Jul; 67(4):336-40. PubMed ID: 2445154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.